A
Arun Bahadur Gurung
Researcher at North Eastern Hill University
Publications - 45
Citations - 578
Arun Bahadur Gurung is an academic researcher from North Eastern Hill University. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 10, co-authored 38 publications receiving 301 citations.
Papers
More filters
Journal ArticleDOI
Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 Mpro enzyme through in silico approach.
Arun Bahadur Gurung,Mohammad Ajmal Ali,Joongku Lee,Mohammad Abul Farah,Khalid Mashay Al-Anazi +4 more
TL;DR: Bonducellpin D exhibited broad-spectrum inhibition potential against SARS- CoV Mpro and MERS-CoV M Pro and therefore is a promising drug candidate, which needs further validations through in vitro and in vivo studies.
Journal ArticleDOI
An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19.
Arun Bahadur Gurung,Mohammad Ajmal Ali,Joongku Lee,Mohammad Abul Farah,Khalid Mashay Al-Anazi +4 more
TL;DR: In this paper, the authors highlight two important categories of computer-aided drug design (CADD), viz., the ligand-based as well as structured-based drug discovery.
Journal ArticleDOI
In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and repurposing of FDA approved antiviral drugs as dual inhibitors.
TL;DR: The present findings suggest that these FDA approved antiviral drugs can be subjected to repurposing against SARS-CoV-2 infection after verifying the in silico results through in vitro and in vivo studies.
Journal ArticleDOI
Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme
Arun Bahadur Gurung,Mohammad Ajmal Ali,Joongku Lee,Mohammad Abul Farah,Khalid Mashay Al-Anazi +4 more
TL;DR: The present work aimed at the identification of suitable lead molecules for the inhibition of 3CLpro enzyme via a computational screening of the Food and Drug Administration (FDA) approved antiviral drugs and phytochemicals.
Journal ArticleDOI
Exploring the physicochemical profile and the binding patterns of selected novel anticancer Himalayan plant derived active compounds with macromolecular targets
TL;DR: Novel anti-cancer plants derived compounds from Himalayan region were docked with defined molecular targets that regulate cell proliferation and apoptosis and Physicochemical profile studies showed that majority of the compounds conform to Lipinski's rule of five having low to high blood brain barrier penetration, human intestinal absorption, plasma binding protein inhibition and P glycoprotein inhibition.